Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Consolidated Net Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Consolidated Net Profit ₹39 Cr₹40 Cr₹35 Cr₹-67 Cr₹12 Cr

What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?

The latest Consolidated Net Profit ratio of NATH BIOGENES (INDIA) is ₹39 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹39 Cr
Mar2024₹40 Cr
Mar2023₹35 Cr
Mar2022₹-67 Cr
Mar2013₹12 Cr

How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹39 Cr
-2.57
Mar2024 ₹40 Cr
13.11
Mar2023 ₹35 Cr
Positive
Mar2022 ₹-67 Cr
Negative
Mar2013 ₹12 Cr -

Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹306.5 Cr -3.3% -5.8% -8.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,384.3 Cr 4.8% -6.3% -22.9% Stock Analytics
KAVERI SEED COMPANY ₹5,244.7 Cr -4.7% -3.9% 17.1% Stock Analytics
VENKYS (INDIA) ₹1,900.9 Cr -0.6% -6.7% -20.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,190.5 Cr -3.2% -7.8% -24.2% Stock Analytics
INDO US BIOTECH ₹243.6 Cr -5.7% NA -48.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.3%

-5.8%

-8.9%

SENSEX

1.4%

2%

10.2%


You may also like the below Video Courses